United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70518-2919_4ab8d0dd-0947-3d29-e063-6294a90ab17a
Product NDC
70518-2919
Form
CAPSULE
Composition / generic term
GABAPENTIN
Labeler
REMEDYREPACK INC.
Marketing category
ANDA
Marketing start / end (source format)
20201023
Source listing expiry
20271231

Source-listed ingredients

  • GABAPENTIN — 400 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BLISTER PACK (70518-2919-1) · 70518-2919-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →